what is a glp-1 receptor agonist Frontiers Study finds GLP-1 receptor agonists

For example, the LEADER trial showed that Liraglutide significantly reduced the risk of major adverse cardiovascular events (MACE) by 13% and cardiovascular death by 22% in comparison to placebo

These potential cardioprotective effects may be related to the favourable actions of metformin on lipid metabolism, vascular smooth muscle, hypercoagulation, platelet hyperactivity, cardiomyocyte intracellular calcium handling and endothelial function [24]

Diabetologia 62:10111023 Laviola L, Leonardini A, Melchiorre M, Orlando MR, Peschechera A, Bortone A et al (2012) Glucagon-like peptide-1 counteracts oxidative stress-dependent apoptosis of human cardiac progenitor cells by inhibiting the activation of the c-Jun N-terminal protein kinase signaling pathway

Oral semaglutide and cardio-vascular outcomes in patients with type 2 diabetes

But as of right now, no, we're not doing that